Evaluation of Tele-expertise for Inmates With a Dermatological Lesion (TLM-Inmates)

January 14, 2016 updated by: Assistance Publique - Hôpitaux de Paris
The purpose of this study is to determine whether Tele-expertise would be effective and cost-effective by reducing the number of secure transportations for inmates in need of a dermatological consultation

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Cergy-Pontoise, France, 95524
        • UCSA Osny
      • Meaux, France, 77351
        • UCSA Meaux
      • Nanterre, France, 92014
        • UCSA Nanterre
      • Réau, France, 77550
        • UCSA Réau
      • Villepinte, France, 93420
        • UCSA Villepinte

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Inmates

Description

Inclusion Criteria:

  • Dermatological expertise required

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control group before telemedicine
Inmates of prisons not having telemedicine before implementation of telemedicine in prisons having telemedicine
Control group after telemedicine
Inmates of prisons not having telemedicine after implementation of telemedicine in prisons having telemedicine
Exposed group, before telemedicine
Inmates of prisons having telemedicine before implementation of telemedicine
Exposed group, after telemedicine
Inmates of prisons having telemedicine after implementation of telemedicine
Device: Telemedicine
Inmates of prisons having telemedicine after implementation of telemedicine

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Proportion of a dermatological expertise among those required
Time Frame: 1 month after the end of the study
1 month after the end of the study

Secondary Outcome Measures

Outcome Measure
Time Frame
Number of hospitalizations for a dermatological reason
Time Frame: 1 month after the end of the study
1 month after the end of the study
Overall costs
Time Frame: 6 months after the end of the study
6 months after the end of the study
Time to a dermatological expertise
Time Frame: 1 month after the end of the study
1 month after the end of the study
Number of usual consultations needed after Tele-expertise
Time Frame: 1 month after the end of the study
1 month after the end of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

Agence Regionale de Sante d'Ile de France

Investigators

  • Principal Investigator: Isabelle Durand-Zaleski, MD, PhD, DRCD URC Eco. Assistance Publique - Hôpitaux de Paris
  • Principal Investigator: François Moreau, MD, Versailles Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

November 27, 2014

First Submitted That Met QC Criteria

December 3, 2014

First Posted (Estimate)

December 5, 2014

Study Record Updates

Last Update Posted (Estimate)

January 15, 2016

Last Update Submitted That Met QC Criteria

January 14, 2016

Last Verified

December 1, 2015

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Teledermatology for Inmates

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skin Disease

Clinical Trials on Telemedicine

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe